No image available

Christopher Stubbs

Associate

Email

christopher.stubbs@aoshearman.com

Phone

+44 20 3088 1185

Offices

London

V-CARD
Christopher is an intellectual property litigator specialising in patent litigation.

He has experience advising a wide range of international clients predominantly in the life sciences and healthcare sector. Christopher has worked on matters before the High Court of Justice and Court of Appeal in the United Kingdom relating to small molecule drugs, monoclonal antibody drugs, pharmaceutical formulation and immunoassays. He has also assisted with the coordination of multi-jurisdictional patent litigation projects.

Christopher is well-placed to advise on the technical aspects of matters due to his research background in the pharmaceutical industry. 

Experience

Representative matters

  • A patent revocation action before the High Court of Justice and Court of Appeal relating to a small molecule drug (previous firm experience). 
  • Coordination of multi-jurisdictional patent disputes for large pharmaceutical companies (previous firm experience). 
  • Preliminary injunction proceedings before the High Court of Justice and Court of Appeal relating to a small molecule drug (previous firm experience). 
  • A patent revocation action before the High Court of Justice relating to a monoclonal antibody product and its associated medical technology (previous firm experience). 
  • A patent revocation action before the High Court of Justice relating to the formulation of a small molecule drug (previous firm experience). 

Recognition

“Chris Stubbs is a lawyer with a great future ahead of him; brilliant technical knowledge”
Legal 500, 2024

Qualifications

Admissions

Admitted as a Solicitor (England and Wales), 2020

Academic

PGDip, Intellectual Property Law and Practice, University of Oxford, 2021 

Legal Practice Certificate, BPP University, 2018 

Graduate Diploma in Law, BPP University, 2017 

MBiolSci Biochemistry, University of Liverpool, 2015 

Disclaimer
A&O Shearman was formed on May 1, 2024 by the combination of Shearman & Sterling LLP and Allen & Overy LLP and their respective affiliates (the legacy firms). Any matters referred to above may include matters undertaken by one or more of the legacy firms rather than A&O Shearman.